Jessica L. Riesterer

Dr. Jessica L. Riesterer

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2022 in Cell Reports Medicine
Verified
Journal Article
Open access
BJBrett E. Johnson
Brett E. Johnson
ACAllison L. Creason
Allison L. Creason
JSJayne Stommel
Jayne Stommel
JKJamie M. Keck
Jamie M. Keck
SPSwapnil Parmar
Swapnil Parmar
JGJoe W. Gray
Joe W. Gray
Mechanisms of therapeutic resistance and vulnerability evolve in metastatic cancers as tumor cells and extrinsic microenvironmental influences change during treatment. To support the development of methods for identifying these mechanisms in individual people, here we present an omic and multidimensional spatial (OMS) atlas generated from four serial biopsies of an individual with metastatic breast cancer during 3.5 years of therapy. This resource links detailed, longitudinal clinical metadata that includes treatment times and doses, anatomic imaging, and blood-based response measurements to clinical and exploratory analyses, which includes comprehensive DNA, RNA, and protein profiles; images of multiplexed immunostaining; and 2- and 3-dimensional scanning electron micrographs. These data report aspects of heterogeneity and evolution of the cancer genome, signaling pathways, immune microenvironment, cellular composition and organization, and ultrastructure. We present illustrative examples of how integrative analyses of these data reveal potential mechanisms of response and resistance and suggest novel therapeutic vulnerabilities.

1 January 2020
Verified
Book Chapter
Closed access
JRJessica L. Riesterer
Jessica L. Riesterer
CLClaudia S López
Claudia S López
ESErin S Stempinski
Erin S Stempinski
MWMelissa Williams
Melissa Williams
KLKevin Loftis
Kevin Loftis
JGJoe W Gray
Joe W Gray

20 October 2020 in eLife
Verified
Journal Article
Open access
GRGraham Rykiel
Graham Rykiel
CLClaudia S López
Claudia S López
JRJessica L. Riesterer
Jessica L. Riesterer
IFIan Fries
Ian Fries
SDSanika Deosthali
Sanika Deosthali
Sandra RugonyiSandra Rugonyi
Sandra Rugonyi
Cardiac pumping depends on the morphological structure of the heart, but also on its subcellular (ultrastructural) architecture, which enables cardiac contraction. In cases of congenital heart defects, localized ultrastructural disruptions that increase the risk of heart failure are only starting to be discovered. This is in part due to a lack of technologies that can image the three-dimensional (3D) heart structure, to assess malformations; and its ultrastructure, to assess organelle disruptions. We present here a multiscale, correlative imaging procedure that achieves high-resolution images of the whole heart, using 3D micro-computed tomography (micro-CT); and its ultrastructure, using 3D scanning electron microscopy (SEM). In a small animal model (chicken embryo), we achieved uniform fixation and staining of the whole heart, without losing ultrastructural preservation on the same sample, enabling correlative multiscale imaging. Our approach enables multiscale studies in models of congenital heart disease and beyond.

15 September 2025 in Nature Methods
Verified
Journal Article
Open access
PDF file
TZTeresa Zulueta-Coarasa
Teresa Zulueta-Coarasa
FJFlorian Jug
Florian Jug
AMAastha Mathur
Aastha Mathur
JMJosh Moore
Josh Moore
AMArrate Muñoz-Barrutia
Arrate Muñoz-Barrutia
MHMatthew Hartley
Matthew Hartley
Artificial intelligence (AI) methods are powerful tools for biological image analysis and processing. High-quality annotated images are key to training and developing new algorithms, but access to such data is often hindered by the lack of standards for sharing datasets. We discuss the barriers to sharing annotated image datasets and suggest specific guidelines to improve the reuse of bioimages and annotations for AI applications. These include standards on data formats, metadata, data presentation and sharing, and incentives to generate new datasets. We are sure that the Metadata, Incentives, Formats and Accessibility (MIFA) recommendations will accelerate the development of AI tools for bioimage analysis by facilitating access to high-quality training and benchmarking data.

6 August 2024 in Acta Biomaterialia
Verified
Journal Article
Closed access
YTYong How Tan
Yong How Tan
KHKrista M Habing
Krista M Habing
JRJessica L. Riesterer
Jessica L. Riesterer
ESErin S. Stempinski
Erin S. Stempinski
SLSteven H. Lewis
Steven H. Lewis
KNKarina Nakayama
Karina Nakayama

25 September 2024 in Biosensors
Verified
Journal Article
Open access
PDF file
JWJason P Ware
Jason P Ware
DSDelaney Shea
Delaney Shea
SNShelby Nicholas
Shelby Nicholas
ESElla A. Stimson
Ella A. Stimson
JRJessica L. Riesterer
Jessica L. Riesterer
SIStuart D. Ibsen
Stuart D. Ibsen
Bacterial membrane vesicle (BMV) nanoparticles are secreted naturally by bacteria throughout their lifecycle and are a rich source of biomarkers from the parent bacteria, but they are currently underutilized for clinical diagnostic applications, such as pathogen identification, due to the time-consuming and low-yield nature of traditional recovery methods required for analysis. The recovery of BMVs is particularly difficult from complex biological fluids. Here, we demonstrate a recovery method that uses dielectrophoretic (DEP) forces generated on electrokinetic microfluidic chips to isolate and analyze BMVs from human plasma. DEP takes advantage of the natural difference in dielectric properties between the BMVs and the surrounding plasma fluid to quickly and consistently collect these particles from as little as 25 µL of plasma. Using DEP and immunofluorescence staining of the LPS biomarker carried on BMVs, we have demonstrated a lower limit of detection of 4.31 × 109 BMVs/mL. The successful isolation of BMVs from human plasma using DEP, and subsequent on-chip immunostaining for biomarkers, enables the development of future assays to identify the presence of specific bacterial species by analyzing BMVs from small amounts of complex body fluid.